⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1405236 | 0.90 | — | — | |
| SCHEMBL1192447 | 0.83 | — | — | |
| SCHEMBL7169842 | 0.83 | DAO (0.31) | — | |
| SCHEMBL19112943 | 0.83 | — | — | |
| SCHEMBL17572317 | 0.83 | — | — | |
| SCHEMBL17147691 | 0.83 | — | — | |
| SCHEMBL13881290 | 0.83 | — | — | |
| SCHEMBL21894787 | 0.78 | — | — | |
| SCHEMBL20580500 | 0.78 | — | — | |
| SCHEMBL16874420 | 0.78 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 77 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-2006527708-A | — | — | 2006-12-07 | — | — | JP | claimed |
| EP-1633346-A1 | PYRROLIDIN-1, 2- DICARBOXYLIC ACID- 1- (4- ETHINYL- PHENYL) - AMID]- 2- (PHENYL)- AMID] DERIVATIVE AS INHIBITORS OF COAGULATION FACTOR XA AND VIIA FOR THE TREATMENT OF THROMBOSIS | MERCK PATENT GmbH (DE) | 2006-03-15 | — | — | EP | claimed |
| EP-1608646-A1 | METHOD FOR THE PRODUCTION OF PYRROLIDINE-1,2-DICARBOXYLIC ACID-1-(PHENYL(-AMIDE))-2-(PHENYL(-AMIDE)) DERIVATIVES AND 1-(PHENYLCARBAMOYL)-PYRROLIDINE-2-CARBOXYLIC ACID DERIVATIVES AS INTERMEDIATE PRODUCTS | MERCK PATENT GmbH (DE) | 2005-12-28 | — | — | EP | claimed |
| WO-2004110433-A1 | PYRROLIDIN-1, 2- DICARBOXYLIC ACID- 1- [(4- ETHINYL- PHENYL) - AMID]- 2- [(PHENYL)- AMID] DERIVATIVE AS INHIBITORS OF COAGULATION FACTOR XA AND VIIA FOR THE TREATMENT OF THROMBOSIS | MERCK PATENT GMBH (DE) | 2004-12-23 | — | — | WO | claimed |
| WO-2004087695-A1 | METHOD FOR THE PRODUCTION OF PYRROLIDINE-1,2-DICARBOXYLIC ACID-1-(PHENYL(-AMIDE))-2-(PHENYL(-AMIDE)) DERIVATIVES AND 1-(PHENYLCARBAMOYL)-PYRROLIDINE-2-CARBOXYLIC ACID DERIVATIVES AS INTERMEDIATE PRODUCTS | MERCK PATENT GMBH (DE) | 2004-10-14 | — | — | WO | claimed |
| EP-3706747-B1 | PRMT5 INHIBITORS | MERCK SHARP & DOHME LLC (US) | 2025-09-03 | — | — | EP | disclosed |
| EP-4567032-A1 | KIF18A INHIBITOR COMPOUND, AND PHARMACEUTICAL COMPOSITION AND PREPARATION METHOD THEREFOR AND USE THEREOF | Changchun Genescience Pharmaceutical Co., Ltd. (CN) | 2025-06-11 | — | — | EP | disclosed |
| CN-119731163-A | KIF18A inhibitor compound, pharmaceutical composition, preparation method and application thereof | 长春金赛药业有限责任公司 | 2025-03-28 | — | — | CN | disclosed |
| US-20200354377-A1 | PRMT5 INHIBITORS | MERCK SHARP & DOHME CORP. (US) | 2020-11-12 | — | — | US | disclosed |
| EP-3706747-A1 | PRMT5 INHIBITORS | Merck Sharp & Dohme Corp. (US) | 2020-09-16 | — | — | EP | disclosed |
| US-20190055204-A1 | COMPOUNDS FOR TREATING DISORDERS MEDIATED BY METABOTROPIC GLUTAMATE RECEPTOR 5, AND METHODS OF USE THEREOF | SUNOVION PHARMACEUTICALS INC. | 2019-02-21 | — | — | US | disclosed |
| US-20190055204-A1 | COMPOUNDS FOR TREATING DISORDERS MEDIATED BY METABOTROPIC GLUTAMATE RECEPTOR 5, AND METHODS OF USE THEREOF | SUNOVION PHARMACEUTICALS INC. | 2019-02-21 | — | — | US | disclosed |
| JP-2000169474-A | ISOQUINUCLIDINE DERIVATIVE AND ITS PRODUCTION AND HYPERCHOLESTEROLEMIA THERAPEUTIC AGENT CONTAINING THE SAME | KOTOBUKI SEIYAKU KK | 2000-06-20 | — | — | JP | disclosed |
| WO-2000031051-A1 | QUINOLINE AND QUINOXALINE COMPOUNDS AS PDGF-RECEPTOR AND/OR LCK TYROSINE KINASE INHIBITORS | AVENTIS PHARMACEUTICALS PRODUCTS INC. (US) | 2000-06-02 | — | — | WO | disclosed |
| EP-1001945-A1 | QUINOLINE AND QUINOXALINE COMPOUNDS WHICH INHIBIT PLATELET-DERIVED GROWTH FACTOR AND/OR p56?lck TYROSINE KINASES | RHONE-POULENC RORER PHARMACEUTICALS, INC. (US) | 2000-05-24 | — | — | EP | disclosed |
| WO-1998054158-A1 | QUINOLINE AND QUINOXALINE COMPOUNDS WHICH INHIBIT PLATELET-DERIVED GROWTH FACTOR AND/OR p56lck TYROSINE KINASES | RHÔNE-POULENC RORER PHARMACEUTICALS INC. (US) | 1998-12-03 | — | — | WO | disclosed |
| WO-1990002123-A1 | AMINO-SUBSTITUTED BRIDGED AZABICYCLIC QUINOLONE CARBOXYLIC ACIDS AND ESTERS | PFIZER INC. (US) | 1990-03-08 | — | — | WO | disclosed |
| US-4804427-A | Composites via in-situ polymerization of composite matrices using a polymerization initiator bound to a fiber coating | ALLIED-SIGNAL INC. (US) | 1989-02-14 | — | — | US | disclosed |
| US-4243591-A | FROM A POLYVINYL CYCLIC AMIDE, FORMALDEHYDE AND PHOSPHOROUS ACID; METAL SEQUESTERANTS, ANTISCALING AGENTS IN WATER TREATMENT | MONSANTO COMPANY (US) | 1981-01-06 | — | — | US | disclosed |
| US-3936444-A | FROM A LACTIM-ETHER AND AN ARYL OR HETEROARYL HYDRAZINE, ACID CATALYST | BAYER AKTIENGESELLSCHAFT (DT) | 1976-02-03 | — | — | US | disclosed |